UltraGreen.ai Limited (ULG) began trading on the Singapore Exchange Mainboard on Dec, 3 2025, opening at US$1.51 per share.
The fluorescence-guided surgery specialist markets the Indocyanine Green product under the names IC-GREEN in the United States and Verdye outside North America. It is expanding its portfolio with the UltraGreen Data Platform, an AI-powered tool designed to provide real-time perfusion insights during surgery.
Chief Executive Officer Ravinder Sajwan said the listing will help the company accelerate commercial expansion, particularly in Asia, and support further product development and clinical validation.
Pol de Win, Head of Global Sales and Origination at SGX Group, noted that UltraGreen.ai’s debut highlights the growing relevance of Singapore’s medical-technology sector.
Comments